Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health

nastya_ph/iStock via Getty Images I first owned Hims & Hers Health, Inc. (NYSE:HIMS) in early 2021, when the company completed its merger with the SPAC, Oaktree Acquisition Corp. SPACs' growing bad reputation, in combination with the falling market, forced me to exit my low-conviction positions, including HIMS. Last Spring, someone from my team brought Hims & Hers back to my attention, so I started to dig in. I decided to do a deep dive into the company to determine if there was enough upside to justify ...